De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
3D Systems Beheer
Beheer criteriumcontroles 2/4
De CEO 3D Systems' is Jeff Graves, benoemd in May2020, heeft een ambtstermijn van 4.42 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 6.54M, bestaande uit 13% salaris en 87% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.77% van de aandelen van het bedrijf, ter waarde $ 2.93M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.5 jaar en 7.3 jaar.
Belangrijke informatie
Jeff Graves
Algemeen directeur
US$6.5m
Totale compensatie
| Percentage CEO-salaris | 13.0% |
| Dienstverband CEO | 4.4yrs |
| Eigendom CEO | 0.8% |
| Management gemiddelde ambtstermijn | 2.5yrs |
| Gemiddelde ambtstermijn bestuur | 7.3yrs |
Recente managementupdates
Recent updates
3D Systems: Green Shoots Amidst Ongoing Macro Challenges
Aug 303D Systems: Don't Print Your Hopes Up At The 52-Week Low
May 30Analyst Estimates: Here's What Brokers Think Of 3D Systems Corporation (NYSE:DDD) After Its Yearly Report
Mar 01
3D Systems: Another Difficult Year Ahead
Feb 293D Systems: Strategic Missteps Uncovered
Feb 153D Systems (NYSE:DDD) Is Carrying A Fair Bit Of Debt
Feb 153D Systems Needs To Do Better
Nov 30At US$4.68, Is It Time To Put 3D Systems Corporation (NYSE:DDD) On Your Watch List?
Nov 153D Systems: No Relief In Sight
Oct 193D Systems Corporation (NYSE:DDD) Shares Could Be 35% Below Their Intrinsic Value Estimate
Oct 053D Systems And The Merger Drama
Sep 273D Systems: The Future Of 3D Printing And Regenerative Healthcare?
Sep 203D Systems: In Search Of Scale
Jul 08Is 3D Systems (NYSE:DDD) Weighed On By Its Debt Load?
Jun 26Does 3D Systems (NYSE:DDD) Have A Healthy Balance Sheet?
Feb 223D Systems inks 3-year technical partnership with Stewart-Haas Racing
Jan 253D Systems: No Hurry - Still Not There Yet
Dec 263D Systems stock gains on promising long-term view after mixed Q3 results
Nov 093D Systems (NYSE:DDD) Has Debt But No Earnings; Should You Worry?
Nov 063D Systems Corporation: Closer But No Cigar Yet
Oct 11An Intrinsic Calculation For 3D Systems Corporation (NYSE:DDD) Suggests It's 41% Undervalued
Sep 233D Systems sets up new firm to support drug development with bioprinting technologies
Sep 08Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$348m |
| Mar 31 2024 | n/a | n/a | -US$350m |
| Dec 31 2023 | US$7m | US$850k | -US$363m |
| Sep 30 2023 | n/a | n/a | -US$96m |
| Jun 30 2023 | n/a | n/a | -US$122m |
| Mar 31 2023 | n/a | n/a | -US$126m |
| Dec 31 2022 | US$6m | US$850k | -US$123m |
| Sep 30 2022 | n/a | n/a | -US$104m |
| Jun 30 2022 | n/a | n/a | US$227m |
| Mar 31 2022 | n/a | n/a | US$250m |
| Dec 31 2021 | US$9m | US$837k | US$322m |
| Sep 30 2021 | n/a | n/a | US$308m |
| Jun 30 2021 | n/a | n/a | -US$57m |
| Mar 31 2021 | n/a | n/a | -US$85m |
| Dec 31 2020 | US$6m | US$489k | -US$150m |
Compensatie versus markt: De totale vergoeding ($USD 6.54M ) Jeff } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 2.40M ).
Compensatie versus inkomsten: De vergoeding van Jeff is gestegen terwijl het bedrijf verliesgevend is.
CEO
Jeff Graves (63 yo)
4.4yrs
Tenure
US$6,535,630
Compensatie
Dr. Jeffrey Alan Graves, also known as Jeff, is Director of Integra LifeSciences Corporation. He is Independent Director of Integra LifeSciences Holdings Corporation from December 12, 2023. Dr. Graves is P...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 4.4yrs | US$6.54m | 0.77% $ 3.2m | |
| Executive Vice President of Industrial Solutions | 4.3yrs | US$2.31m | 0.27% $ 1.1m | |
| Executive VP | less than a year | US$845.99k | 0.13% $ 542.7k | |
| Executive VP | 3.2yrs | US$2.10m | 0.12% $ 504.2k | |
| Co-Founder | no data | geen gegevens | 0.43% $ 1.8m | |
| Executive Vice President of Engineering & Operations | 1.8yrs | geen gegevens | 0.11% $ 464.3k | |
| Treasurer & VP of Investor Relations | no data | geen gegevens | geen gegevens | |
| President - Regenerative Medicine | less than a year | geen gegevens | 0.096% $ 392.3k |
2.5yrs
Gemiddelde duur
60.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van DDD wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.5 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 4.8yrs | US$6.54m | 0.77% $ 3.2m | |
| Co-Founder | no data | geen gegevens | 0.43% $ 1.8m | |
| Independent Director | 28.8yrs | US$220.00k | 0.36% $ 1.5m | |
| Independent Director | 8.9yrs | US$228.76k | 0.24% $ 980.4k | |
| Independent Director | 25yrs | US$245.00k | 0.18% $ 742.4k | |
| Independent Chairman of the Board | 7.6yrs | US$400.00k | 0.11% $ 468.3k | |
| Independent Director | 16.8yrs | US$255.00k | 0.11% $ 436.0k | |
| Independent Director | 7.3yrs | US$240.00k | 0.11% $ 464.0k | |
| Chair of Medical Advisory Board | 2.4yrs | geen gegevens | geen gegevens | |
| Independent Director | 5.6yrs | US$240.00k | 0.094% $ 385.2k | |
| Independent Director | 3.8yrs | US$216.24k | 0.088% $ 361.4k | |
| Independent Director | 2.8yrs | US$218.11k | 0.075% $ 304.7k |
7.3yrs
Gemiddelde duur
70yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van DDD wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.3 jaar).